Replies to post #197793 on Biotech Values

[DewDiligence]

TEVA sells 54M ADRs @$62.50—a 2% discount to the closing price on 11/27/15:

http://finance.yahoo.com/news/teva-announces-pricing-public-offerings-033500053.html

TEVA has also sold $3.375B of preferred stock that automatically converts into common stock on 12/15/18. The conversion price is $62.50-75.00, based on the market price at the time of conversion.

The $6.58B net proceeds from the two offerings will be used to pay a portion of the consideration for AGN’s generic-drug business.